# FDAcategoryC - Schema.org Enumeration Member

> Source: https://schema.org/FDAcategoryC
> Extracted: 2026-02-16T18:44:30.753Z

---

**Note**: You are viewing the development version of [Schema.org](https://schema.org/). See [how we work](https://schema.org/docs/howwework.html) for more details.

A Schema.org Enumeration Member

  [Thing](https://schema.org/Thing "Thing") \> [Intangible](https://schema.org/Intangible "Intangible") \> [Enumeration](https://schema.org/Enumeration "Enumeration") \> [MedicalEnumeration](https://schema.org/MedicalEnumeration "MedicalEnumeration") \> [DrugPregnancyCategory](https://schema.org/DrugPregnancyCategory "DrugPregnancyCategory") ::   [FDAcategoryC](https://schema.org/FDAcategoryC "FDAcategoryC")  

**\[more...\]**

-   Canonical URL: https://schema.org/FDAcategoryC
-   [Check for open issues.](https://github.com/schemaorg/schemaorg/issues?q=is%3Aissue+is%3Aopen+FDAcategoryC)

A designation by the US FDA signifying that animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.

A member value for enumeration type: [DrugPregnancyCategory](https://schema.org/DrugPregnancyCategory "DrugPregnancyCategory")